Insight & Intelligence

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

March 01, 2008 (Vol. 28, No. 5)

Optimizing Transient Gene Expression

Applications Expected to Move Beyond Discovery and the Preclinic to Clinical Realm

  • Transient gene expression represents an appealing and complementary alternative to the development of stable cell lines for the expression of bioengineered proteins, according to experts in the field. Yves Durocher, Ph.D., project leader from the National Research Council Biotechnology Research Institute in Montréal, Canada, and his colleagues  optimized ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.